Novavax
stock was climbing Tuesday after the company announced that an initial one million doses of its Covid-19 vaccine are now available for use in the U.K.
Shares of
Novavax
(ticker: NVAX) have struggled this year, tumbling 86% so far in 2022, and 90% in the past 12 months. The company slashed its full-year revenue guidance back in August, and posted a disappointing second quarter amid poor demand for its Covid-19 vaccine.
BANGKOK: A blast on Sunday at a building in northeastern Myanmar said to have been storing explosives for mining has...
Hilary Duff was catapulted into stardom as the lead of Disney Channel’s Lizzie McGuire when she was just 13, and...
In the famous Tennessee Williams play, Cat on a Hot Tin Roof, Big Daddy says: "There ain't nothin' more powerful...
This article was written byFollowFred Piard, PhD. is a quantitative analyst and IT professional with over 30 years of experience...
Last week Microsoft Israel, the local marketing and sales office of the US software giant, announced the departure of...
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.
